# Albatroz Therapeutics Pte.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/albatroz-therapeutics-pte

- Industry: Biotechnology
- Headquarters: Singapore, Singapore
- Website: www.albatroztherapeutics.com
- Total disclosed funding: $3M
- Latest round: Seed (Apr 25, 2023)
- Investors on record: 2

## About

Based in Singapore, and founded in 2020 by Frederic Bard (CEO), and Guy Heathers, Albatroz Therapeutics Pte. Ltd. operates as a biotechnology company that focuses on tissue remodeling to cure cancer and treat arthritis. In April 2023, Albatroz Therapeutics Pte. Ltd. raised USD 3 million in venture funding co-led by Outram Bio Pte. Ltd. and SEEDS Capital.

Albatroz Therapeutics Pte. Ltd. operator of the biotechnology company wants to use extracellular matrix remodeling to treat solid tumors and arthritic disorders. The company provides an approach that effectively reduces the growth of solid tumors in various parts of the body while also providing a cure for arthritis, allowing patients to recover from cancer while also preventing the progression of arthritis.

The company plans to use the April 2023 funding to help accelerate the development of therapeutic antibodies.

## Funding rounds

- Seed, Apr 25, 2023, $3M — SEEDS Capital, Outram Bio

## Investors

- SEEDS Capital (https://capitalatlas.ai/funds/seeds-capital) — Seed
- Outram Bio (https://capitalatlas.ai/funds/outram-bio) — Seed